Status:
WITHDRAWN
MgSO4 vs Metoclopramide for Headache in Pregnant Women
Lead Sponsor:
Women and Infants Hospital of Rhode Island
Conditions:
Headache
Eligibility:
FEMALE
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
The study will compare effectiveness of intravenous magnesium sulfate to that of intravenous metoclopramide (Reglan®) for acute headache in pregnant women. We will randomize pregnant women who present...
Detailed Description
Metoclopramide and prochlorperazine (Compazine®), antiemetic dopamine receptor antagonists, are widely used for headache treatment in North American emergency departments. Metoclopramide, FDA pregnanc...
Eligibility Criteria
Inclusion
- Pregnant, 18-75
- Headache rated 4 or greater on a 0-10 pain scale
Exclusion
- New objective neurologic abnormality at the time of exam
- Temperature \>100.4
- Allergy or intolerance to study medications
- Suspected of confirmed preeclampsia/eclampsia
- Complete heart block
- Hypotension, SBP\<85
- Myasthenia gravis
- End stage renal failure
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00632606
Start Date
August 1 2008
End Date
March 1 2010
Last Update
December 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States, 02905